Sequence variations in EBNA-1 may dictate restriction of tissue distribution of Epstein-Barr virus in normal and tumour cells

References

1. Adldinger H. K., Delius H., Freese U. K., Clarke J., Bornkamm G. W. 1985; A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes. Virology 141:121–134
   [Google Scholar]
2. Allday M. J., Crawford D. H. 1988; Role of epithelium in EBV persistence and pathogenesis of B-cell tumors. Lancet i:855–857
   [Google Scholar]
3. Anagnostopoulos I., Hummel M., Kreschel C., Stein H. 1995; Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis : implications for the interindividual infection route of Epstein-Barr virus. Blood 85:744–750
   [Google Scholar]
4. Bhatia K., Raj A., Gutiérrez M. I., Judde J.-G., Spangler G., Venkatesh H., Magrath I. T. 1996; Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13:177–181
   [Google Scholar]
5. Boyle M. J., Sewell W. A., Sculley T. B., Apolloni A., Turner J. J., Swanson C. E., Penny R., Cooper D. A. 1991; Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non- Hodgkin lymphoma. Blood 78:3004–3011
   [Google Scholar]
6. Duarte E. A., Novella I. S., Weaver S. C., Domingo E., Wain-Hobson S., Clarke D. K., Moya A., Elena S. F., de la Torre J. C., Holland J. J. 1994; RNA virus quasispecies : significance for viral disease and epidemiology. Infectious Agents and Disease 3:201–214
   [Google Scholar]
7. Eigen M. 1993; The origin of genetic information; viruses as models. Gene 135:37–47
   [Google Scholar]
8. Goldschmidts W. L., Bhatia K., Johnson J. F., Akar N., Gutiérrez M. I., Shibata D., Carolan M., Levine A., Magrath I. 1992; Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt’s lymphomas. Leukemia 6:875–878
   [Google Scholar]
9. Klein G. 1994; The paradoxical coexistence of EBV and the human species. Epstein-Barr Virus Report 1:5–9
   [Google Scholar]
10. Knox P. G., Li Q. X., Rickinson A. B., Young L. S. 1996; In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus : cell interaction observed in nasopharyngeal carcinoma. Virology 215:40–50
    [Google Scholar]
11. Magrath I., Jain V., Bhatia K. 1993; Molecular epidemiology of Burkitt’s lymphoma. Epstein-Barr Virus Associated Diseases 225:377–396
    [Google Scholar]
12. Miller G. 1990; Epstein-Barr virus: biology, pathogenesis and medical aspects. In Fields Virology, 2nd edn.. pp 1921–1958 Fields B. N., Knipe D. M. Edited by New York: Raven Press;
    [Google Scholar]
13. Molla A., Korneyeva M., Gao Q., Vasasanonda S., Schipper P., Mo H. M., Markowitz M., Chernyavskiy T., Niu P., Lyons N., Hssu A. 1996; Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nature Medicine 2:760–766
    [Google Scholar]
14. Rowe M., Young L. S., Cadwallader K., Petti L., Kieff E., Rickinson A. B. 1989; Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins. Journal of Virology 63:1031–1039
    [Google Scholar]
15. Sample J., Young L. S., Martin B., Chatman T., Kieff E., Rickinson A. B. 1990; Epstein-Barr virus types 1 and 2 differ in their EBNA 3A, 3B and 3C genes. Journal of Virology 64:4084–4092
    [Google Scholar]
16. Sculley T. B., Apolloni A., Stumm R., Moss D. J., Mueller-Lantczh N., Misko I. S., Cooper D. A. 1989; Expression of Epstein-Barr virus nuclear antigens 3, 4 and 6 are altered in cell lines containing B type virus. Virology 171:401–408
    [Google Scholar]
17. Sixbey J. W., Shirley P., Chesney P. J., Buntin D. M., Resnick L. 1989; Detection of a second widespread strain of Epstein-Barr virus. Lancet 2:761–765
    [Google Scholar]
18. Snudden D. K., Smith P. R., Lai D., Ng M.-H., Griffin B. E. 1995; Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumors. Oncogene 10:1545–1552
    [Google Scholar]
19. Tao Q., Srivastava G., Chan A. C., Chung L. P., Loke S. L., Ho F. C. 1995; Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. Journal of Medical Virology 45:71–77
    [Google Scholar]
20. Wilson J. B., Bell J. L., Levine A. J. 1996; Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO Journal 15:3117–3126
    [Google Scholar]
21. Wrightham M. N., Stewart J. P., Janjua N. J., Pepper S. D., Sample C., Rooney C. M., Arrand J. R. 1995; Antigenic and sequence variation in the C terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208:521–530
    [Google Scholar]
22. Yao Q. Y., Rickinson A. B., Epstein M. A. 1985; A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. International Journal of Cancer 35:35–42
    [Google Scholar]
23. zur Hausen H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., Santesson L. 1970; EBV DNA in biopsies of Burkitt’s tumors and anaplastic carcinomas of the nasopharynx. Nature 228:1056–1058
    [Google Scholar]